Ginsenoside Rg1 protection against β-amyloid peptide-induced neuronal apoptosis via estrogen receptor α and glucocorticoid receptor-dependent anti-protein nitration pathway

Neuropharmacology. 2012 Sep;63(3):349-61. doi: 10.1016/j.neuropharm.2012.04.005. Epub 2012 Apr 17.

Abstract

Ginsenoside Rg1 (Rg1) acts as a neuroprotective agent against various insults, however, the underlying mechanism has not been fully elucidated yet. Here, we report that Rg1 protects primary rat cerebrocortical neurons against β-amyloid peptide₂₅₋₃₅ (Aβ₂₅₋₃₅) injury via estrogen receptor α (ERα) and glucocorticoid receptor (GR)-dependent anti-protein nitration pathway. In primary rat cerebrocortical neuron cultures under basal conditions, Rg1 leads to nuclear translocation of ERα and GR, induces related responsive gene PR, pS₂ and MKP-1, SGK transcription. Meantime, Rg1 also increases the basal level of ERK1/2 phosphorylation. In the presence of toxic level of Aβ₂₅₋₃₅, Rg1 maintains ERK1/2 phosphorylation, attenuates iNOS expression, NO production, and inhibits NF-κB nuclear translocation, protein nitration and cell death. The antiapoptotic effects of Rg1 via both ERα and GR were abolished by small interfering RNAs (siRNA). ERK1/2 phosphorylation inhibitor U0126 can block downstream iNOS expression and NO generation. Interestingly, the anti-protein nitration effect of Rg1 is well matched with ERα and GR activation, although its anti-ROS production effect is in an ERα- and GR-independent manner. These results suggest that Rg1 ameliorates Aβ₂₅₋₃₅-induced neuronal apoptosis at least in part by two complementary ERα- and GR-dependent downstream pathways: (1) upregulation of ERK1/2 phosphorylation followed by inhibiting iNOS expression, NO generation and protein tyrosine nitration. (2) reduction NF-κB nuclear translocation. These data provide new understanding into the mechanisms of Rg1 anti-apoptotic functions after Aβ₂₅₋₃₅ exposure, suggesting that ERα and GR-dependent anti-protein tyrosine nitration pathway might take an important role in the neuroprotective effect of Rg1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / antagonists & inhibitors*
  • Amyloid beta-Peptides / toxicity*
  • Animals
  • Apoptosis / drug effects*
  • Blotting, Western
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Estrogen Receptor alpha / drug effects*
  • Female
  • Ginsenosides / pharmacology*
  • Immunohistochemistry
  • Mitogen-Activated Protein Kinases / physiology
  • NF-kappa B / metabolism
  • Neurons / drug effects*
  • Neuroprotective Agents*
  • Pregnancy
  • RNA, Small Interfering
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Nitrogen Species / metabolism
  • Reactive Oxygen Species / metabolism
  • Real-Time Polymerase Chain Reaction
  • Receptors, Glucocorticoid / drug effects*
  • Signal Transduction / drug effects

Substances

  • Amyloid beta-Peptides
  • Estrogen Receptor alpha
  • Ginsenosides
  • NF-kappa B
  • Neuroprotective Agents
  • RNA, Small Interfering
  • Reactive Nitrogen Species
  • Reactive Oxygen Species
  • Receptors, Glucocorticoid
  • Mitogen-Activated Protein Kinases
  • ginsenoside Rg1